链脲佐菌素诱导大鼠2型糖尿病并发症模型研究进展
基金项目:

广西科技基础条件平台建设项目(10-108-19)


Research advance of type 2 diabetes complications rat models induced by streptozotocin
Author:
Fund Project:

Guangxi Science and Technology Infrastructure construction project (10-108-19)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • | |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    糖尿病是一种内分泌代谢性疾病,主要有1型糖尿病和2型糖尿病,其中患者绝大部分为2型糖尿病,且病程缓慢,并常伴有不同程度的心脑血管、肾、视网膜、以及神经病变等并发症。糖尿病并发症的发生率、致残率和致死率都相当高,为其治疗带来了巨大的挑战。目前,国内外在2型糖尿病并发症动物模型方面进行了研究与探讨,主要通过注射链脲佐菌素(STZ)诱导大鼠2型糖尿病并发症,该造模方法能较好的模拟出类似人类2型糖尿病并发症病变特征,为2型糖尿病的预防与治疗提供了一定的参考价值

    Abstract:

    Diabetes is a kind of endocrine metabolic disease, which mainly including type 1 diabetes and type 2 diabetes, most of them are the latter, with low course and different degrees of complications. The incidence rate, disability rate and fatality rate of diabetes are quite high, which bring a big challenge for the treatment. For now, there are many researches and discussions in animal models of type 2 diabetes complications at home and abroad, mainly through the injection of STZ to induce type 2 diabetes complications, which can show the lesion characteristics better, all of these study can provide some references for the prevention and curing of type 2 diabetes.

    参考文献
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

陈永欣.链脲佐菌素诱导大鼠2型糖尿病并发症模型研究进展[J].中国比较医学杂志,2013,23(3).

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2013-01-02
  • 最后修改日期:2013-01-20
  • 录用日期:2013-02-20
  • 在线发布日期: 2013-03-21
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭